statistiche ricercatore

Continente	#
NA - Nord America	1.088
AS - Asia	480
EU - Europa	383
SA - Sud America	86
Continente sconosciuto - Info sul continente non disponibili	42
AF - Africa	11
OC - Oceania	6
Totale	2.096

Nazione	#
US - Stati Uniti d'America	1.059
SG - Singapore	163
VN - Vietnam	129
IT - Italia	105
CN - Cina	78
RU - Federazione Russa	71
BR - Brasile	61
HK - Hong Kong	44
DE - Germania	34
GB - Regno Unito	30
FI - Finlandia	25
FR - Francia	24
SE - Svezia	20
CA - Canada	18
LV - Lettonia	12
ID - Indonesia	11
ES - Italia	10
KR - Corea	10
NL - Olanda	10
AR - Argentina	9
IN - India	9
AT - Austria	7
BD - Bangladesh	7
PL - Polonia	7
AU - Australia	6
CZ - Repubblica Ceca	6
EC - Ecuador	6
MX - Messico	6
ZA - Sudafrica	6
IQ - Iraq	5
BG - Bulgaria	4
CH - Svizzera	4
CO - Colombia	4
IL - Israele	4
PH - Filippine	4
UA - Ucraina	3
AE - Emirati Arabi Uniti	2
BE - Belgio	2
CL - Cile	2
DZ - Algeria	2
JP - Giappone	2
KE - Kenya	2
KZ - Kazakistan	2
LT - Lituania	2
RO - Romania	2
SK - Slovacchia (Repubblica Slovacca)	2
TR - Turchia	2
VE - Venezuela	2
AF - Afghanistan, Repubblica islamica di	1
AZ - Azerbaigian	1
CU - Cuba	1
DK - Danimarca	1
GT - Guatemala	1
HN - Honduras	1
IR - Iran	1
JM - Giamaica	1
JO - Giordania	1
KG - Kirghizistan	1
MA - Marocco	1
MD - Moldavia	1
NI - Nicaragua	1
OM - Oman	1
PE - Perù	1
PY - Paraguay	1
RS - Serbia	1
SA - Arabia Saudita	1
UZ - Uzbekistan	1
Totale	2.054

Nome	#
Some Gram-negative lipoproteins keep their surface topology when transplanted from one species to another and deliver foreign polypeptides to the bacterial surface	241
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models	239
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine	208
Synergistic protective activity of tumor-specific epitopes engineered in bacterial outer membrane vesicles	206
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli	193
Vaccinology: The art of putting together the right ingredients	188
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	178
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform	173
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells	137
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine	119
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles	117
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells	97
Totale	2.096

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	95	0	0	0	6	7	7	2	16	12	13	11	21
2022/2023	145	21	15	8	27	5	26	0	11	14	1	7	10
2023/2024	78	1	4	2	2	1	25	5	6	2	11	2	17
2024/2025	372	7	1	31	70	12	39	4	17	12	70	24	85
2025/2026	861	73	33	90	159	81	58	170	22	65	61	28	21
2026/2027	156	15	27	60	54	0	0	0	0	0	0	0	0
Totale													2.096